Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Methylprednisolone in COVID-19 ARDS
NCT04499313Phase 3Unknown
- Sponsor
- Chattogram General Hospital
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone, methylprednisolone in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Chattogram General Hospital. Status: unknown.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04499313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499313.